贝瑞基因：聘任王一迪为公司证券事务代表

Group 1 - Berry Genomics announced the resignation of its securities affairs representative, Song Xiaofeng, due to the expiration of her contract, and appointed Wang Yidi as the new representative effective October 30, 2025 [1] - For the first half of 2025, Berry Genomics reported that its revenue was entirely derived from the genetic testing industry, with a 100.0% contribution [2] - As of the latest update, Berry Genomics has a market capitalization of 4.5 billion yuan [3]